Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

This interview segment highlights additional points on bimekizumab and psoriasis related to patient-reported outcomes (PROs) in the 3 year BE RADIANT study.

Skin Clearance and Psoriasis Improvements from Bimekizumab, With Ron Vender, MD

In this segment of his interview, Vender highlighted his own views on the significance of BE RADIANT trial findings on bimekizumab for psoriasis.

Interpreting 3-Year Data on Bimekizumab from BE RADIANT, With Ron Vender, MD

This interview with Vender highlights recent findings on patient-reported outcomes (PROs) in patients in the BE RADIANT trial with psoriasis.

3-Year Patient-Reported Psoriasis Outcomes for Bimekizumab, With Ron Vender, MD

In the phase 3b BE RADIANT trial and its open-label extension, bimekizumab treatment led to durable improvements in patient-reported outcomes over 3 years.

BE RADIANT Trial: Bimekizumab Effective for Psoriasis After 3 Years of Use

These data, released by Lilly, suggest ixekizumab (Taltz) and tirzepatide (Zepbound) are more effective when used together versus ixekizumab monotherapy.

Ixekizumab, Tirzepatide Effective Together for Psoriasis and Obesity or Overweight

Dermatology leaders preview 2026 breakthroughs including oral psoriasis drugs, new biologics, novel acne drugs, and AI tools transforming patient care.

What’s Next in Dermatology? Dermatologists Weigh In On 2026

Eichenfield speaks in this interview about several key takeaways drawn from her master class in pediatric dermatology at Maui Derm Hawaii.

New Pediatric Atopic Dermatitis Updates for 2026, With Dawn Eichenfield, MD, PhD

This Q&A interview with Philip Mease, MD, highlights his contribution to the ‘Psoriasis Update 2026’ talk given at the 2026 Maui Derm Hawaii meeting.

Spotlighting Updates in Psoriasis, PsA Management in 2026, With Philip Mease, MD

This interview at Maui Derm 2026 highlights notable takeaways regarding psoriasis treatment strategies and emerging therapies.

Discussing Psoriasis Treatment Updates for 2026, With Eingun James Song, MD

In this analysis presented at Maui Derm, indirect comparisons were made between risankizumab and icotrokinra in patients with psoriasis.

Risankizumab Compared to Icotrokinra in Adult Patients with Psoriasis

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.

Plaque Psoriasis